PAVmed enters at-the-market equity sales agreement for up to USD 9.4 million of stock
PAVM•At-the-market equity program
PAVmed entered an at-the-market sales agreement with A.G.P./Alliance Global Partners to issue common stock from time to time.
- Program size set at USD 9.4 million under a prospectus supplement dated Sept. 9, 2026.
- Sales agent commission fixed at 3% of aggregate gross proceeds.
- Net proceeds earmarked for working capital, general corporate purposes.
